World Health Organization (WHO)Last Updated 24 January 2022.
10 Vaccines Approved for Use by WHO
-
Novavax
Nuvaxovid- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 32 countries
11 trials in 7 countries
Approval Source: extranet.who.int
-
Serum Institute of India
COVOVAX (Novavax formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 3 countries
2 trials in 1 country
Approval Source: extranet.who.int
-
Moderna
Spikevax- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 85 countries
45 trials in 19 countries
Approval Source: extranet.who.int
-
Pfizer/BioNTech
Comirnaty- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 136 countries
58 trials in 24 countries
Approval Source: extranet.who.int
-
Janssen (Johnson & Johnson)
Ad26.COV2.S- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 106 countries
18 trials in 18 countries
Approval Source: extranet.who.int
-
Oxford/AstraZeneca
Vaxzevria- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 137 countries
56 trials in 30 countries
Approval Source: extranet.who.int
-
Serum Institute of India
Covishield (Oxford/AstraZeneca formulation)- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 47 countries
2 trials in 1 country
Approval Source: extranet.who.int
-
Bharat Biotech
Covaxin- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 13 countries
7 trials in 1 country
Approval Source: extranet.who.int
-
Sinopharm (Beijing)
Covilo- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 88 countries
22 trials in 11 countries
Approval Source: extranet.who.int
-
Sinovac
CoronaVac- Phase 1
- Phase 2
- Phase 3
- Approved
This vaccine is approved.
Approved in 52 countries
29 trials in 9 countries
Approval Source: extranet.who.int